- €17.03m
- -€6.76m
- €3.18m
- 42
- 31
- 14
- 16
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.44 | ||
| Price to Tang. Book | 0.48 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.78 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -12.22% | ||
| Return on Equity | -7.82% | ||
| Operating Margin | -134.94% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 1.22 | 16.93 | 162.72 | 38.49 | 3.18 | n/a | n/a | 6.65% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +660.67 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Nanorepro AG is a Germany-based company active in the biotechnology sector. The Company is engaged in the research of stem cells, which are used in the medical treatment due to their ability to self-renew and differentiate to a range of specialized cell types. Nanorepro AG gathers samples of patients’ stem cells and stores them for the future use. Its portfolio also comprises OTC rapid diagnostic tests, such as OvuQUICK, an ovulation test for women; GraviQUICK, a pregnancy test; MenoQUICK, a menopause test; VagiQUICK, a vaginal yeast test; GlutenCHECK, a test to detect celiac disease; CholesterinCHECK, a test to measure the level of total cholesterol, HDL and LDL, as well as FertiQUICK, a fertility test for men.
Directors
- Olaf Stiller CSU (41)
- Lisa Juengst CEO
- Michael Tillmann VSU
- Stefan Pieh CFO
- Bhuwnesh Agrawal SUB
- Rainer Barth SUB
- Clemens Jakopitsch SUB
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- October 17th, 2007
- Public Since
- October 9th, 2012
- No. of Employees
- 22
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
XETRA- Shares in Issue
- 12,803,827
- Address
- Untergasse 8, MARBURG AN DER LAHN, 35037
- Web
- https://www.nanorepro.com/
- Phone
- +49 6421951449
- Contact
- Lisa Juengst
- Auditors
- PanTaxAudit GmbH Wirtschaftsprufungsgesellschaft
Upcoming Events for NN6
Similar to NN6
Aap Implantate AG
XETRA
Bio-Gate AG
XETRA
FAQ
As of Today at 22:11 UTC, shares in NanoRepro AG are trading at €1.33. This share price information is delayed by 15 minutes.
Shares in NanoRepro AG last closed at €1.33 and the price had moved by -28.11% over the past 365 days. In terms of relative price strength the NanoRepro AG share price has underperformed the FTSE Global All Cap Index by -29.91% over the past year.
There is no consensus recommendation for this security.
Find out moreNanoRepro AG does not currently pay a dividend.
NanoRepro AG does not currently pay a dividend.
NanoRepro AG does not currently pay a dividend.
To buy shares in NanoRepro AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €1.33, shares in NanoRepro AG had a market capitalisation of €17.03m.
Here are the trading details for NanoRepro AG:
- Country of listing: Germany
- Exchange: GER
- Ticker Symbol: NN6
Based on an overall assessment of its quality, value and momentum NanoRepro AG is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like NanoRepro AG. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -24.53%.
As of the last closing price of €1.33, shares in NanoRepro AG were trading -15.39% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The NanoRepro AG PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €1.33.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
NanoRepro AG's management team is headed by:
- Olaf Stiller - CSU
- Lisa Juengst - CEO
- Michael Tillmann - VSU
- Stefan Pieh - CFO
- Bhuwnesh Agrawal - SUB
- Rainer Barth - SUB
- Clemens Jakopitsch - SUB